A Trial of Digoxin Before Second-Trimester Abortion
Completed · Not applicable
Conditions studied: Induced Abortion
In brief
The purpose of our study is to determine the optimum route for the injection of digoxin prior to second-trimester surgical abortion.
Key facts
- Study ID
- NCT01047748
- Run by
- White, Katharine O'Connell, M.D., M.P.H.
- People needed
- 272
- Starts
- 2011-01-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2013-05-01
Who can join
Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- at least 18 years old
- English or Spanish speaking
- be able to give informed consent
- documented fetal cardiac activity.
You may not qualify if…
- significant medical illness or cardiovascular disease
- current use of cardiac or antihypertensive medications
- cardiac arrhythmia on preoperative EKG
- multiple gestation
- morbid obesity (BMI greater than 40)
- known digoxin allergy
Where it is running
- Planned Parenthood Los Angeles - Bixby Health Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.